Clinical Microbiology Reviews, April 2001, p. 364-381, Vol. 14, No. 2
0893-8512/01/$04.00+0 DOI: 10.1128/CMR.14.2.364-381.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Department of Pathology1 and Clinical Microbiology Laboratories,3 Massachusetts General Hospital, Boston, Massachusetts 02114, and Department of Pathology, Harvard Medical School, Boston, Massachusetts 021152
The specter of bioterrorism has captured the attention of government and military officials, scientists, and the general public. Compared to other sectors of the population, clinical microbiologists are more directly impacted by concerns about bioterrorism. This review focuses on the role envisioned for clinical laboratories in response to a bioterrorist event. The microbiology and clinical aspects of the biological agents thought to be the most likely tools of bioterrorists are presented. The historical background of the problem of bioterrorism and an overview of current U.S. preparedness planning, with an emphasis on the roles of health care professionals, are also included.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Vaccine Immunol. |
|---|---|
| J. Clin. Microbiol. | ALL ASM JOURNALS |